1. Home
  2. PRQR vs DYNC Comparison

PRQR vs DYNC Comparison

Compare PRQR & DYNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

N/A

Current Price

$1.63

Market Cap

262.5M

Sector

Health Care

ML Signal

N/A

Logo Dynamix Corporation Class A Ordinary Shares

DYNC

Dynamix Corporation Class A Ordinary Shares

N/A

Current Price

$10.90

Market Cap

238.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PRQR
DYNC
Founded
2012
2024
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
262.5M
238.8M
IPO Year
2014
2024

Fundamental Metrics

Financial Performance
Metric
PRQR
DYNC
Price
$1.63
$10.90
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
★ $8.22
N/A
AVG Volume (30 Days)
★ 511.7K
32.3K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.20
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$10.76
52 Week High
$3.10
$10.99

Technical Indicators

Market Signals
Indicator
PRQR
DYNC
Relative Strength Index (RSI) 31.81 52.32
Support Level $1.64 $10.76
Resistance Level $1.99 $10.97
Average True Range (ATR) 0.08 0.02
MACD -0.02 -0.00
Stochastic Oscillator 10.00 50.00

Price Performance

Historical Comparison
PRQR
DYNC

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

About DYNC Dynamix Corporation Class A Ordinary Shares

Dynamix Corp is a blank check company.

Share on Social Networks: